Genfit - Product Pipeline Review - 2012 - This pharmaceuticals report, "Genfit - Product Pipeline Review - 2012" provides data on the Genfit's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from our proprietary databases, Genfit's corporate website, SEC filings, investor presentations and featured press releases, both from Genfit and industry-specific third party sources, put together by This team.
Scope
- Genfit - Brief Genfit overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Genfit human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Genfit with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Genfit's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Genfit's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Genfit in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Genfit's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Genfit.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Genfit and identify potential opportunities in those areas.
Keywords
Current R&D Portfolio of Genfit; Genfit - Key Therapeutics; Genfit - Pipeline Overview and Promising Molecules; Genfit - News; Genfit - Latest Updates; Genfit - Pipeline; Genfit - Discontinued/Dormant Projects
Table of Contents
Table of Contents
List of Tables
List of Figures
Genfit Snapshot
Genfit Overview
Key Information
Key Facts
Genfit - Research and Development Overview
Key Therapeutic Areas
Genfit - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Genfit - Pipeline Products Glance
Genfit Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Genfit - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Genfit - Drug Profiles
G15750
Product Description
Mechanism of Action
R&D Progress
GFT1229
Product Description
Mechanism of Action
R&D Progress
GFT505
Product Description
Mechanism of Action
R&D Progress
GFT679
Product Description
Mechanism of Action
R&D Progress
MKG02
Product Description
Mechanism of Action
R&D Progress
SAVX1
Product Description
Mechanism of Action
R&D Progress
SERX1
Product Description
Mechanism of Action
R&D Progress
SOL02
Product Description
Mechanism of Action
R&D Progress
TGFTX1 Program
Product Description
Mechanism of Action
R&D Progress
TGFTX2 Program
Product Description
Mechanism of Action
R&D Progress
TGFTX3 Program
Product Description
Mechanism of Action
R&D Progress
Genfit - Pipeline Analysis
Genfit - Pipeline Products by Therapeutic Class
Genfit - Pipeline Products by Route of Administration
Genfit - Pipeline Products By Mechanism of Action
Genfit - Recent Pipeline Updates
Genfit - Dormant Projects
Genfit - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AVE-0847
AVE-8134
Genfit - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Genfit, Recent Developments
Genfit- Press Release
Jun 20, 2012: Genfit To File Investigational New Drug Application With FDA For GFT505
May 10, 2012: Genfit Announces Preclinical Data Of GFT505 Promotes Liver Fibrosis Regression
May 04, 2012: Genfit Announces Results From Phase I Study Of GFT505
Apr 19, 2012: Genfit To Present Latest Clinical Results For GFT505 In NASH At 47th EASL Congress
Apr 04, 2012: GENFIT Receives Scientific Advice From EMA On Efficacy Of GFT505
Feb 23, 2012: GENFIT Receives New Patents For GFT505 In Major Countries
Feb 08, 2012: GENFIT Announces Conclusive Results Of Regulatory Toxicology Studies With GFT505
Feb 03, 2012: GENFIT's GFT505-210-6 Phase II Clinical Study Reaches All Primary And Secondary Efficacy Objectives
Nov 26, 2009: Genfit Announces Complementary Beneficial Effects Of Its Drug Candidate GFT505 For Atherogenic Dyslipidemia
Nov 26, 2009: Genfit Announces Phase II Study Results Of GFT505
Financial Deals Landscape
Genfit, Deals Summary
Genfit, Pharmaceuticals & Healthcare, Deal Details
Partnerships
ImaBiotech Enters Into Agreement With Genfit
Genfit Enters Into Research Agreement With Sanofi-Aventis
Genfit Extends Co-Development Agreement With Sanofi-Aventis
Genfit Extend Co-Development Agreement With Servier
Genfit Extends Co-Development Agreement With Pierre Fabre
Bicoll Enters Into Research Agreement With Genfit
Genfit Extends Drug Discovery Agreement With Sanofi-Aventis
Genfit Expands Agreement With Solvay Group
Genfit Enters Into Agreement With Bicoll And University of Freiburg
Equity Offering
Genfit Completes Private Placement Of Common Stock For $7.2 Million
Genfit Completes Private Placement Of $20 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Genfit, Key Information
Genfit, Key Facts
Genfit - Pipeline by Indication, 2012
Genfit - Pipeline by Stage of Development, 2012
Genfit - Monotherapy Products in Pipeline, 2012
Genfit - Phase II, 2012
Genfit - Pre-Clinical, 2012
Genfit - Discovery, 2012
Genfit - Pipeline By Therapeutic Class, 2012
Genfit - Pipeline By Route of Administration, 2012
Genfit - Pipeline Products By Mechanism of Action, 2012
Genfit - Recent Pipeline Updates, 2012
Genfit - Dormant Developmental Projects,2012
Genfit - Discontinued Pipeline Products, 2012
Genfit, Subsidiaries
Genfit, Deals Summary
ImaBiotech Enters Into Agreement With Genfit
Genfit Enters Into Research Agreement With Sanofi-Aventis
Genfit Extends Co-Development Agreement With Sanofi-Aventis
Genfit Extend Co-Development Agreement With Servier
Genfit Extends Co-Development Agreement With Pierre Fabre
Bicoll Enters Into Research Agreement With Genfit
Genfit Extends Drug Discovery Agreement With Sanofi-Aventis
Genfit Expands Agreement With Solvay Group
Genfit Enters Into Agreement With Bicoll And University of Freiburg
Genfit Completes Private Placement Of Common Stock For $7.2 Million
Genfit Completes Private Placement Of $20 Million
List of Figures
Genfit - Pipeline by Indication, 2012
Genfit - Pipeline by Stage of Development, 2012
Genfit - Monotherapy Products in Pipeline, 2012
Genfit - Pipeline By Therapeutic Class, 2012
Genfit - Pipeline Products By Mechanism of Action, 2012 29